title: Cutaneous tissue expressions of matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 are associated with a high degree of disability at diagnosis of hanseniasis.
authors.affiliation: Postgraduate Program in Pathology of Federal University of Health Sciences of Porto Alegre, Brazil.
authors.forename: Kelly A M
authors.initials: KA
authors.lastname: Teixeira
authors.affiliation: Dermatology Department of Clinical Hospital, Porto Alegre, Brazil.
authors.forename: Gabriela
authors.initials: G
authors.lastname: Garbin
authors.affiliation: LZ Laboratory.
authors.forename: Laura
authors.initials: L
authors.lastname: Luzzatto
authors.affiliation: Health Department of Rio Grande do Sul State, Brazil.
authors.forename: Letícia M
authors.initials: LM
authors.lastname: Eidt
authors.affiliation: Postgraduate Program in Pathology of Federal University of Health Sciences of Porto Alegre, Brazil.|Health Department of Rio Grande do Sul State, Brazil.
authors.forename: Renan R
authors.initials: RR
authors.lastname: Bonamigo
mesh_terms: D015415:Biomarkers / Q000097:blood; D003430:Cross-Sectional Studies; D004185:Disability Evaluation; D005260:Female; D006801:Humans; D007918:Leprosy / Q000175:diagnosis / Q000378:metabolism*; D008297:Male; D020778:Matrix Metalloproteinase 2 / Q000378:metabolism*; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism*; D011379:Prognosis; D018570:Risk Assessment; D012720:Severity of Illness Index
chemical_list: D015415:Biomarkers; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9